tetraethylammonium has been researched along with Glioblastoma in 1 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weaver, AK | 1 |
| Liu, X | 1 |
| Sontheimer, H | 1 |
1 other study available for tetraethylammonium and Glioblastoma
| Article | Year |
|---|---|
Role for calcium-activated potassium channels (BK) in growth control of human malignant glioma cells.
Topics: Apoptosis; Blotting, Western; Cell Death; Cell Division; Cell Line, Tumor; Culture Media, Serum-Free | 2004 |